SCHEMBL23928878

SCHEMBL23928878

O=C1CC2(CN(C(=O)O)C2)Oc2cc(F)ccc21

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 4/20 0.54
HSD11B1 P28845 1/20 0.49
HDAC8 Q9BY41 6/20 0.41
HDAC6 Q9UBN7 6/20 0.41
HDAC3 O15379 5/20 0.41
HDAC4 P56524 5/20 0.41
HDAC1 Q13547 5/20 0.41
HDAC7 Q8WUI4 5/20 0.41
HDAC2 Q92769 5/20 0.41
HDAC10 Q969S8 5/20 0.41
HDAC11 Q96DB2 5/20 0.41
HDAC9 Q9UKV0 5/20 0.41
HDAC5 Q9UQL6 5/20 0.41
MAOB P27338 3/20 0.39
CYP19A1 P11511 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14918958 0.88 HSD11B1 (0.59) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL19030659 0.82 EPHX2 (0.39) CHRNA7HSD11B1
SCHEMBL23928845 0.82 CHRNA7 (0.51) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL17708825 0.81 CHRNA7 (0.50) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL23928896 0.81 SIGMAR1 (0.53) CHRNA7HDAC8HDAC6HDAC3HDAC4
SCHEMBL29920633 0.80 HSD11B1 (0.48) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL21617956 0.79 CHRNA7 (0.50) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL2588090 0.78 HSD11B1 (0.72) HSD11B1HDAC8HDAC6HDAC3HDAC4
SCHEMBL620216 0.77 KDM4E (0.52) CHRNA7HSD11B1HDAC8HDAC6HDAC3
SCHEMBL29920628 0.77 KDM4E (0.52) CHRNA7HSD11B1HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 CHRNA7 1/4885HSD11B1 157/4885HDAC8 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.